Cotrimoxazole as a Preventative Intervention for Pneumocystis Pneumonia in Pemphigus Patients Treated with Rituximab: A Retrospective Study
Journal
Dermatology and therapy
Date Issued
2023-06-15
Author(s)
Abstract
Pneumocystis jirovecii pneumonia (PJP) is a severe, life-threatening complication in patients treated with rituximab. However, there is no consensus on the primary prophylaxis for it in rituximab-treated pemphigus patients. Therefore, we sought to investigate the prophylactic efficacy and safety profile of cotrimoxazole for reducing the risk of developing PJP in pemphigus patients receiving rituximab.
Subjects
Corticosteroid
Cotrimoxazole
Pemphigus
Pneumocystis pneumonia
Prophylaxis
Rituximab
SDGs
Type
journal article